May 23, 2025
Eisai to Present E7386, Co-created by PRISM BioLab and Eisai, at the ASCO (American Society of Clinical Oncology) Annual Meeting
TOKYO, Japan, 23 May 2025: -- PRISM BioLab, Co. Ltd. , a leading discovery and development...
Read More
May 14, 2025
Announcement: Investor Relations Seminar for Individual Investors
CEO Dai Takehara will participate in the "103rd IR Seminar for Individual Investors" hosted by Logmi...
Read More
May 10, 2025
Featured in Nikkei Biotech
Nikkei Biotech has published an interview with our CEO Dai Takehara, and our Director/Head of R&D...
Read More
April 14, 2025
Featured in The Nikkei
PRISM BioLab has been featured in The Nikkei (Nihon Keizai Shimbun). "PRISM BioLab and AI Drug...
Read More
April 13, 2025
PRISM BioLab and Elix Join Forces to Accelerate AI-Driven Drug Discovery for Protein-Protein Interaction Targets
TOKYO, Japan, 14 April 2025 -- PRISM BioLab, Co. Ltd., a leading discovery and development biotechnology...
Read More
March 13, 2025
Announcement: Guest Appearance on Radio NIKKEI 1’s The Money – Thursday, Hideaki Sakurai’s Kabutetsu
Our CEO, Takehara, recently appeared on Radio NIKKEI 1’s The Money – Thursday, Hideaki Sakurai’s Kabutetsu....
Read More
February 21, 2025
Announcement: Participation in LINK-J’s Miyaman’s Venture Talk vol.12
We are pleased to announce that our CEO, Takehara, will be speaking at Miyaman's Venture Talk...
Read More
December 26, 2024
Announcement of Appointment and Resignation of Directors
We are pleased to announce that at our Ordinary General Meeting of Shareholders held on December...
Read More
December 16, 2024
Our CEO Takahara Featured on “IRTV” Video Media
Our CEO, Takahara, recently appeared on IRTV, a video platform connecting investors and companies. YouTube: IRTV...
Read More
December 16, 2024
Event Report: CTO Toma Speaks at LINK-J and Merck Co-hosted Symposium
On Wednesday, November 13, 2024, our CTO, Toma, delivered a presentation at the symposium titled "Chemistry...
Read More